Genprex

-$0.05 (-2.03%) Today

+$0.03 (+1.24%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Genprex and other ETFs, options, and stocks.

About GNPX

Genprex, Inc. is a clinical-stage gene therapy company, which engages in the development of therapies for patients with cancer and diabetes. The company’s lead product candidate is REQORSA immunogene therapy drug for non-small cell lung cancer.

CEO

J. Rodney Varner

Employees

Headquarters

Austin, Texas

Founded

2009

GNPX Key Statistics

Market Cap

114.54M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

253.38K

High Today

$2.54

Low Today

$2.35

Open Price

$2.50

Volume

378.18K

52 Week High

$7.72

52 Week Low

$2.24

GNPX Earnings

-$0.14

-$0.09

-$0.05

$0.00

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Estimated

— per share

Actual

Expected Nov 11, After Hours

Why Robinhood?

Genprex, Inc. is a clinical-stage gene therapy company, which engages in the development of therapies for patients with cancer and diabetes. The company’s lead product candidate is REQORSA immunogene therapy drug for non-small cell lung cancer. View more

Genprex, Inc. is a clinical-stage gene therapy company, which engages in the development of therapies for patients with cancer and diabetes. The company’s lead product candidate is REQORSA immunogene therapy drug for non-small cell lung cancer.